NASDAQ:GWPH

GW Pharmaceuticals (GWPH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$218.96
$218.96
50-Day Range
$216.90
$219.28
52-Week Range
$87.07
$219.57
Volume
N/A
Average Volume
899,771 shs
Market Capitalization
$6.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GWPH stock logo

About GW Pharmaceuticals Stock (NASDAQ:GWPH)

GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.

GWPH Stock News Headlines

GWPRF Historical Data
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
George Washington University
GW Pharmaceuticals PLC (GWPRF)
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.
GWPH Jan 2023 195.000 put
GW Pharmaceuticals (GWPH): What Awaits in Q1 Earnings?
See More Headlines
Receive GWPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GW Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2020
Today
4/22/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GWPH
Fax
N/A
Employees
1,161
Year Founded
N/A

Profitability

Net Income
$-9,020,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$311.33 million
Cash Flow
$0.01 per share
Book Value
$23.48 per share

Miscellaneous

Free Float
N/A
Market Cap
$6.86 billion
Optionable
Optionable
Beta
2.15
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


GWPH Stock Analysis - Frequently Asked Questions

How were GW Pharmaceuticals' earnings last quarter?

GW Pharmaceuticals plc (NASDAQ:GWPH) released its quarterly earnings data on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) earnings per share for the quarter, topping analysts' consensus estimates of ($0.63) by $0.27. The biopharmaceutical company earned $137.10 million during the quarter, compared to analyst estimates of $97.66 million. GW Pharmaceuticals had a negative net margin of 11.05% and a negative trailing twelve-month return on equity of 7.46%. The firm's revenue for the quarter was up 50.7% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.04) earnings per share.

What is Justin Gover's approval rating as GW Pharmaceuticals' CEO?

14 employees have rated GW Pharmaceuticals Chief Executive Officer Justin Gover on Glassdoor.com. Justin Gover has an approval rating of 80% among the company's employees.

What other stocks do shareholders of GW Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GW Pharmaceuticals investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Tesla (TSLA), Intel (INTC), Netflix (NFLX), Gilead Sciences (GILD), Advanced Micro Devices (AMD).

This page (NASDAQ:GWPH) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners